Assessing the Impact of Using Heparin and Bivalirudin on Clinical Outcome of Subjects Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.
Background: Bivalirudin is increasingly used as an alternative to heparin in patients undergoing percutaneous coronary intervention (PCI) due to its potential for reducing adverse clinical outcomes. This meta-analysis aimed to compare the effectiveness and safety of bivalirudin versus heparin across...
| Publicado en: | Iranian Journal of Public Health Vol. 54; no. 12; pp. 2579 - 2595 |
|---|---|
| Autores principales: | , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Tehran University of Medical Sciences
Dec2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |